STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Clinical trials for STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tests aggressive BP management to protect heart and kidneys in cancer patients
Disease control OngoingThis phase II trial tests whether intensive blood pressure management (targeting systolic BP below 120 mmHg) is better than standard care (below 140 mmHg) for patients with advanced kidney or thyroid cancer starting anti-angiogenic TKI therapy. The study enrolls 61 participants a…
Matched conditions: STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Phase: NA • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy tackles cancer in HIV patients
Disease control OngoingThis early-phase trial tests the safety of combining two cancer drugs, nivolumab and cabozantinib, in people with HIV who have advanced solid tumors. Only 8 participants were enrolled. The goal is to see if the combination is safe and can shrink or stabilize tumors.
Matched conditions: STAGE IV THYROID GLAND MEDULLARY CARCINOMA AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC